Cargando…
Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816737/ https://www.ncbi.nlm.nih.gov/pubmed/29455270 http://dx.doi.org/10.1007/s40800-018-0077-0 |
_version_ | 1783300734726438912 |
---|---|
author | Larsen, Timothy R. McMunn, Jedediah Ahmad, Hala AlMahameed, Soufian T. |
author_facet | Larsen, Timothy R. McMunn, Jedediah Ahmad, Hala AlMahameed, Soufian T. |
author_sort | Larsen, Timothy R. |
collection | PubMed |
description | A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electrocardiography demonstrated ventricular tachycardia and QT interval prolongation (corrected QT interval was 597 ms). He was diagnosed with loperamide-induced QT prolongation resulting in incessant ventricular tachycardia. Loperamide was discontinued, and he was treated with electrolyte replacement, supportive care, and monitoring. After 5 days, his electrocardiogram (ECG) normalized and he had no more ventricular tachycardia. A Naranjo assessment score of 8 was obtained, indicating a probable relationship between QT prolongation and his use of loperamide. Large doses of loperamide can cause QT interval prolongation and life-threatening arrhythmias. These effects may be accentuated when histamine-2 receptor blockers are also abused. |
format | Online Article Text |
id | pubmed-5816737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-58167372018-02-27 Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse Larsen, Timothy R. McMunn, Jedediah Ahmad, Hala AlMahameed, Soufian T. Drug Saf Case Rep Case Report A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electrocardiography demonstrated ventricular tachycardia and QT interval prolongation (corrected QT interval was 597 ms). He was diagnosed with loperamide-induced QT prolongation resulting in incessant ventricular tachycardia. Loperamide was discontinued, and he was treated with electrolyte replacement, supportive care, and monitoring. After 5 days, his electrocardiogram (ECG) normalized and he had no more ventricular tachycardia. A Naranjo assessment score of 8 was obtained, indicating a probable relationship between QT prolongation and his use of loperamide. Large doses of loperamide can cause QT interval prolongation and life-threatening arrhythmias. These effects may be accentuated when histamine-2 receptor blockers are also abused. Springer International Publishing 2018-02-17 /pmc/articles/PMC5816737/ /pubmed/29455270 http://dx.doi.org/10.1007/s40800-018-0077-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report Larsen, Timothy R. McMunn, Jedediah Ahmad, Hala AlMahameed, Soufian T. Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse |
title | Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse |
title_full | Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse |
title_fullStr | Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse |
title_full_unstemmed | Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse |
title_short | Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse |
title_sort | ventricular tachycardia triggered by loperamide and famotidine abuse |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816737/ https://www.ncbi.nlm.nih.gov/pubmed/29455270 http://dx.doi.org/10.1007/s40800-018-0077-0 |
work_keys_str_mv | AT larsentimothyr ventriculartachycardiatriggeredbyloperamideandfamotidineabuse AT mcmunnjedediah ventriculartachycardiatriggeredbyloperamideandfamotidineabuse AT ahmadhala ventriculartachycardiatriggeredbyloperamideandfamotidineabuse AT almahameedsoufiant ventriculartachycardiatriggeredbyloperamideandfamotidineabuse |